Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company is a biopharmaceutical company, develops, manufactures, and sells biopharmaceuticals for diabetes, cancer, and autoimmune conditions.
Biocon Limited, is a listed public company incorporated on 29 November, 1978. It is classified as a public limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 625.00 cr and the total paid-up capital is INR 600.30 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
14.65%
-61.54%
3208.25%
34.88%
1609.75%
46.92%
-2.89
-2.34
121.33
25.03
-1.35
0.11
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(9)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Vistra (ITCL) India Limited
No. of Loans: 1
Total Amount : 1,070.0 cr
Catalyst Trusteeship Limited
No. of Loans: 1
Total Amount : 500.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 197.5 cr
DEPARTMENT OF BIOTECHNOLOGY
No. of Loans: 1
Total Amount : 5.7 cr
Department of Biotechnology
No. of Loans: 1
Total Amount : 4.4 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Naina Lal Kidwai | 00017806 | 3 years |
| Director | Bobby Kanubhai Parikh | 00019437 | 6 years |
| Director | Ravi Rasendra Mazumdar
Shareholder
|
00109213 | 24 years |
| Director | Kiran Mazumdar Shaw
Shareholder
|
00347229 | 15 years |
| Director | Rekha Mehrotra Menon | 02768316 | 1 years |
| Kmp | Siddharth Mittal | <HIDDEN> | 5 years |
| Managing Director | Siddharth Mittal
Shareholder
|
03230757 | 5 years |
| Director | Atul Dhawan | 07373372 | 1 years |
| Director | Nicholas Robert Haggar | 08518863 | 1 years |
| Director | Eric Vivek Mazumdar
Shareholder
|
09381549 | 3 years |
| CS | Mayank Verma | <HIDDEN> | 5 years |
| Kmp | Mukesh Katapadi Kamath | <HIDDEN> | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| NAYARA ENERGY LIMITED |
Active
|
1,490.6 Cr | 1 | Gujarat |
| ROTHSCHILD & CO INDIA PRIVATE LIMITED |
Active
|
13.5 Cr | 1 | Maharashtra |
| UPL LIMITED |
Active
|
150.1 Cr | 1 | Gujarat |
| GLAND PHARMA LTD |
Active
|
16.5 Cr | 1 | Telangana |
| BMR BUSINESS SOLUTIONS PRIVATE LIMITED |
Active
|
8.5 L | 1 | Maharashtra |
| TAXAND ADVISORS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Delhi |
| BMR GLOBAL SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| INDOSTAR CAPITAL FINANCE LIMITED |
Active
|
136.1 Cr | 1 | Maharashtra |
| AVAANA CAPITAL ADVISORS LLP |
Active
|
13,333.0 | 1 | Maharashtra |
| INFOSYS LIMITED |
Active
|
2,076.1 Cr | 1 | Karnataka |
| BIOCON BIOLOGICS LIMITED |
Active
|
1,758.3 Cr | 3 | Karnataka |
| RELIANCE PETROLEUM LIMITED |
Amalgamated
|
4,500.0 Cr | 1 | Gujarat |
| CLINIGENE INTERNATIONAL LIMITED |
Amalgamated
|
5.0 L | 2 | Karnataka |
| GLENLOCH PROPERTIES LLP |
Active
|
1.0 L | 2 | Karnataka |
| BIOCON BIOPHARMACEUTICALS LIMITED |
Amalgamated
|
17.6 Cr | 1 | Karnataka |
| CSEP RESEARCH FOUNDATION |
Active
|
1.0 L | 1 | Delhi |
| IMMUNEEL THERAPEUTICS PRIVATE LIMITED |
Active
|
4.6 L | 1 | Karnataka |
| NARAYANA VAISHNO DEVI SPECIALTY HOSPITALS PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Karnataka |
| BIOCON RESEARCH LIMITED |
Active
|
5.0 L | 1 | Karnataka |
| BIOCON BIOSPHERE LIMITED |
Active
|
288.6 Cr | 3 | Karnataka |
| SCIENCE GALLERY BENGALURU |
Active
|
0.0 | 1 | Karnataka |
| BIOFUSION THERAPEUTICS LIMITED |
Active
|
5.0 L | 2 | Karnataka |
| MAZUMDAR SHAW MEDICAL FOUNDATION |
Active
|
1.0 L | 1 | Karnataka |
| NARAYANA HRUDAYALAYA LIMITED |
Active
|
204.4 Cr | 1 | Karnataka |
| BIOCON PHARMA LIMITED |
Active
|
887.1 Cr | 3 | Karnataka |
| BIOCON ACADEMY |
Active
|
5.0 L | 2 | Karnataka |
| TRENT LIMITED |
Active
|
35.5 Cr | 1 | Maharashtra |
| SYNGENE INTERNATIONAL LIMITED |
Active
|
402.5 Cr | 1 | Karnataka |
| ACCENTURE SERVICES PRIVATE LIMITED |
Amalgamated
|
3.0 Cr | 1 | Maharashtra |
| INVEST INDIA |
Active
|
1.0 Cr | 1 | Delhi |
| COREOBJECTS INDIA PRIVATE LIMITED |
Amalgamated
|
58.0 L | 1 | Karnataka |
| JOPASANA SOFTWARE & SYSTEMS PRIVATE LIMI TED |
Amalgamated
|
1.0 Cr | 1 | Karnataka |
| DELOITTE FOUNDATION |
Active
|
20,000.0 | 1 | Maharashtra |
| MAKING AN IMPACT THAT MATTERS FOUNDATION |
Active
|
20,000.0 | 1 | Maharashtra |
| DELOITTE SHARED SERVICES INDIA LLP |
Active
|
2.7 Cr | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| SYNGENE INTERNATIONAL LIMITED | Karnataka | 1993 | ₹ 402.5 Cr |
| BIOCON ACADEMY | Karnataka | 2013 | ₹ 5.0 L |
| BIOCON PHARMA LIMITED | Karnataka | 2014 | ₹ 887.1 Cr |
| Biocon SA, | Switzerland | - | - |
| Biocon Biologics Limited | India | - | - |
| Biocon Biologics UK Limited | United Kingdom | - | - |
| Biocon Biologics SDN BHD | Malaysia | - | - |
| Biocon Pharma Inc | United States | - | - |
| Biocon FZ LLC | United Arab Emirates | - | - |
| Biocon Biologics Healthcare Malaysia SDN BHD | Malaysia | - | - |
| Syngene USA Inc | United States | - | - |
| Biocon Pharma UK Limited | United Kingdom | - | - |
| Biocon Pharma Ireland Limited | Ireland | - | - |
| Biocon Biologics Inc, USA | United States | - | - |
| BIOCON BIOSPHERE LIMITED | Karnataka | 2019 | ₹ 288.6 Cr |
| Biocon Biologics FZ LLC | United Arab Emirates | - | - |
| Biocon Biologics Do Brasil Ltda | Brazil | - | - |
| Biocon Pharma Malta Limited | Malta | - | - |
| Biocon Pharma Malta I Limited | Malta | - | - |
| BIOFUSION THERAPEUTICS LIMITED | Karnataka | 2021 | ₹ 5.0 L |
| SYNGENE MANUFACTURING SOLUTIONS LIMITED | Karnataka | 2022 | ₹ 1.0 Cr |
| SYNGENE SCIENTIFIC SOLUTIONS LIMITED | Karnataka | 2022 | ₹ 399.0 Cr |
| Biocon Biologics Germany GmbH | Germany | - | - |
| Biocon Biologics Canada Inc. | Canada | - | - |
| Biosimilars Newco Limited | United Kingdom | - | - |
| Biosimilar Collaborations Ireland Limited | Ireland | - | - |
| BIOCON SA | Switzerland | - | - |
| BIOCON BIOLOGICS LIMITED | India | - | - |
| BIOCON BIOLOGICS UK LIMITED | United Kingdom | - | - |
| BIOCON SDN BHD | Malaysia | - | - |
| Biocon Biologics Inc | United States | - | - |
| Biocon Biologics Germany GmbH, Germany | Germany | - | - |
| Biocon Biologics Canada Inc, Canada | Canada | - | - |
| Biosimilars NewCo Limited, UK | United Kingdom | - | - |
| Biosimilar Collaborations Ireland limited, Ireland | Ireland | - | - |
The incorporation date of BIOCON LIMITED is 29 November, 1978
The authorized share capital of BIOCON LIMITED is INR ₹ 625.0 Cr.
The paid-up capital of BIOCON LIMITED is INR ₹ 600.3 Cr.
The registered address of BIOCON LIMITED is 20th KM, Hosur Road, Electronic City Bengaluru Bangalore Karnataka - 560100
The CIN number of BIOCON LIMITED is L24234KA1978PLC003417.
Expand
Delete
Collapse
See
details
